Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information (Tables)

9. Segment and Geographic Information (Tables)

3 Months Ended

Jun. 30, 2014

	Three Months Ended June 30,
	2014		2013
U.S.	$	1,028,000	$	1,323,000
Mexico		1,470,000		1,424,000
Europe and other		672,000		407,000
	$	3,170,000	$	3,154,000

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details